Market Overview:

The Blood Collection Market size is estimated to reach $3.2 billion by 2030, growing at a CAGR of 5.7% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, Blood Collection Market – By Product Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Rapid Serum Tubes, and Others), By Material Type (Plastic, Glass), By End-Use (Hospitals & Clinics, R&D Centers, Diagnostic Centers, and Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030”

Technological advancements in blood collection systems and Growth in emerging markets and healthcare infrastructure are expected to create growth opportunities in the market during forecast period.

North America Dominated the Market in 2023:

North America accounted for the largest share of 36% of the Blood Collection Market in 2023 followed by Europe and APAC. The U.S. in particular has witnessed a large demand for Blood Collection in health care systems, mainly due to the advancements made in diagnostic technologies for a wide range of patient populations. New technologies like blood tests for heart disease prediction and blood-sampling robots are emerging in the blood collection space.

Blood Collection Market: Key Takeaways

Increasing Focus on Safety and Minimally Invasive Techniques:

The development of safety-engineered devices, such as retractable needles and needle-free systems, is driven by the need to reduce healthcare-associated infections (HAIs) and prevent needlestick injuries among healthcare workers. These innovations are gaining importance as healthcare organizations prioritize patient and staff safety. Furthermore, minimally invasive blood sampling techniques, like micro sampling and capillary blood collection, are becoming popular due to their ease of use, reduced pain, and enhanced patient compliance, particularly for pediatric and geriatric populations.

Growing Demand for Point-of-Care Blood Collection:

The rise in demand for point-of-care (POC) blood collection, particularly in home-based and decentralized healthcare settings. The COVID-19 pandemic accelerated this shift, as patients increasingly seek convenient healthcare solutions. Portable blood collection devices and self-monitoring kits are becoming more popular, driven by the need for frequent monitoring of chronic conditions such as diabetes, cardiovascular diseases, and cancer. This trend aligns with the growing focus on personalized medicine and home-based diagnostics, providing patients with more control over their health management. 

For More Queries About "Blood Collection Market " @ https://www.industryarc.com/pdfdownload.php?id=511347

Scope of the Report: 

Report Metric 

Details 

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

5.7%

Market Size in 2030

$3.2 billion

Segments Covered

By Product Type, By Material Type, By End-Use

Geographies Covered

North America (USA, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of APAC), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and Rest of the World (Middle East, and Africa).

 

    1.  Sekisui Chemical Co., Ltd.

2.  QIAGEN N.V.

3.  Bio – X

4.  CML Biotech

5.  Hebei Xinle Sci &Tech Co., Ltd.

6.  Greiner Bio-One

7.  Becton, Dickinson & Company (BD)

8.  AdvaCare Pharma

9.  FL Medical S.r.l.

     10. Sarstedt AG & Co.


Recent Developments:

  •  In May 2024, QIAGEN's launch of the QIAseq Multimodal DNA/RNA Library Kit enhances the blood collection market by streamlining the preparation of DNA and RNA libraries for next-generation sequencing (NGS) from a single sample.
  •  In April 2024, BD India launched UltraTouch™; a new age blood collection device targeted to minimize patient pain and discomfort as well as enable single prick success during blood collection process.
  •  In May 2023, CML Biotech Ltd., manufacturers of blood collection tubes in India, has installed the world’s first integrated machine ‘Husky –Ichor’, for manufacturing blood collection tubes.

Blood Collection Market: Competitive Landscape

Key companies profiled in the Blood Collection Market are Sekisui Chemical Co., Ltd., QIAGEN N.V., Bio – X, CML Biotech, Hebei Xinle Sci &Tech Co., Ltd., Greiner Bio-One, Becton, Dickinson & Company (BD), AdvaCare Pharma, FL Medical S.r.l., Sarstedt AG & Co., and Others.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 
 
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.

Contact Us:

Mr. Venkat Reddy
IndustryARC
USA: (+1) 518-282-4727